Given our strategic location in the heart of Maryland’s vibrant biotech landscape, and our unique access to speciality items such as Enbrel and other injectables, Blue Door Pharma has become the “go to” distributor for many procurement officers.
Blue Door Pharma’s current customers are primarily US-based biotech companies with a general focus on pharmaceutical and biopharmaceutical research and development, and include some of the leaders in the industry, all who appreciate the value, quality, and service we provide.
Enbrel (Etanercept) is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF); by acting as a TNF inhibitor. It has FDA approval to treat rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis.
Enbrel comes in four dosage forms: 1) 50 mg Single-use Prefilled Syringe (3) 0.98 mL of a 50 mg/mL solution of etanercept; 2) 50 mg Single-use Prefilled SureClick Autoinjector, 0.98 mL of a 50 mg/mL solution of etanercept; 3) 25 mg Single-use Prefilled Syringe 0.51 mL of a 50 mg/mL solution of etanercept; and 4) 25 mg Multiple-use Vial 25 mg of etanercept.